$AMRN News Article - Latest Research Evaluating VASCEPA /VAZKEPA (icosapent ethyl) and Subgroups from the REDUCE-IT Landmark Outcomes Trial to be Presented at the European Society of Cardiology (ESC) Congress
https://marketwirenews.com/news-releases/late...35130.html